These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34850014)

  • 1. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes.
    Triolo TM; Pyle L; Broncucia H; Armstrong T; Yu L; Gottlieb PA; Steck AK
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1510-e1517. PubMed ID: 34850014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
    Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L;
    Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R; Gombos Z; Gyürüs E; Soltész G
    Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?
    Fouts A; Pyle L; Yu L; Miao D; Michels A; Krischer J; Sosenko J; Gottlieb P; Steck AK;
    Diabetes Care; 2016 Oct; 39(10):1738-44. PubMed ID: 27456836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.
    Steck AK; Fouts A; Miao D; Zhao Z; Dong F; Sosenko J; Gottlieb P; Rewers MJ; Yu L;
    Diabetes Technol Ther; 2016 Jul; 18(7):410-4. PubMed ID: 26991969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher prevalence of autoantibodies to insulin and GAD65 in Swedish compared to Lithuanian children with type 1 diabetes.
    Holmberg H; Vaarala O; Sadauskaite-Kuehne V; Ilonen J; Padaiga Z; Ludvigsson J
    Diabetes Res Clin Pract; 2006 Jun; 72(3):308-14. PubMed ID: 16442659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes.
    Gu Y; Jia X; Vartak T; Miao D; Dong F; Jerram ST; Rewers M; Ferrara A; Lawrence JM; Yu L; Leslie RD;
    Diabetologia; 2021 Sep; 64(9):2052-2060. PubMed ID: 34272582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Diabetes From Childhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype.
    Urrutia I; Martínez R; Calvo B; Saso-Jiménez L; González P; Fernández-Rubio E; Martín-Nieto A; Aguayo A; Rica I; Gaztambide S; Castano L
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1341-e1346. PubMed ID: 37207452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
    Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
    Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
    Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
    Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
    Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
    Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
    Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
    Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
    Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.